Oruka Therapeutics, Inc. (ORKA)

Nasdaq · Healthcare · Biotechnology
$95.81-1.80%As of 2026-11-22 · USD
Last session low $93.30Last session high $97.23
52-week low $25.2352-week high $115.52
Market cap
$6.50B
Sector
Healthcare

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)46.9In the neutral range (30 to 70)
MACD (12, 26, 9)2.54Below its signal line (3.81); histogram -1.27
Bollinger %B (20, 2)33%Inside the bands (89.42 to 109.05)
SMA 2099.23Price is 3.4% below
SMA 5090.07Price is 6.4% above
SMA 20074.23Price is 29.1% above
ATR (20)5.75% of priceAverage true range per day
52-week position78%In the upper part of the 25.23 to 115.52 range

About Oruka Therapeutics, Inc.

Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications.

Insider filings, 90 daysNo purchases and 18 sales (about $20.6M).

More in Biotechnology